Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
The Lancet Haematology in conversation with
More Info
The Lancet Haematology in conversation with
Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome
Aug 22, 2024
The Lancet Group

Professor Matteo Giovanni Della Porta joins us to discuss the primary analysis of the phase 3 COMMANDS trial comparing luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndrome patients.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Episode Artwork Matteo Della Porta on the phase 3 COMMANDS trial examining luspatercept versus epoetin alfa in patients with lower-risk myleodysplastic syndrome 8:08 Episode Artwork Kim Linton on follicular lymphoma 9:48 Episode Artwork Judy Truong on ferritin reference levels and iron deficiency 11:17 Episode Artwork Johannes Schetelig on remission induction versus immediate allogeneic HSCT for patients with AML 14:11 Episode Artwork Banu Aygun on sickle cell anaemia 11:13 Episode Artwork Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia 18:06 Episode Artwork Elisabeth Schorb on the MARTA phase 2 trial 9:23 Episode Artwork Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies 13:03 Episode Artwork Dr Sarah O'Brien on the PREVAPIX-ALL trial 13:50 Episode Artwork Enrico Lopriore on haemolytic disease of the fetus and newborn 12:33 Episode Artwork Meletios Dimopoulos on relapsed and refractory multiple myeloma 11:00 Episode Artwork Eric Ohuma on haemoglobin concentrations and neonatal outcomes 16:27 Episode Artwork Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding 13:13 Episode Artwork Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma 16:32 Episode Artwork Alok Srivastava on fitusiran for patients with haemophilia A and B 18:41 Episode Artwork Emmanuela E Ambrose on stroke prevention in children with sickle cell disease 11:31 Episode Artwork Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes 22:10 Episode Artwork Xiao-Jun Huang on cellular therapy in China 28:10 Episode Artwork Glenn Pierce on haemophilia care in LMICs 34:55 Episode Artwork Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders 12:50 Episode Artwork Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline 15:05 Episode Artwork Fredrik Schjesvold on OCEAN phase 3 12:24 Episode Artwork Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia 11:59 Episode Artwork Raul Cordoba on haematological malignancies in older people 16:24 Episode Artwork Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria 9:03